| Income Statement |
| Total Revenue | 5.15M |
|
| Revenues (USD) | 5.15M |
| Cost of Revenue | 2.21M |
| Gross Profit | 2.94M |
| Operating Expenses | 3.66M |
| Research and Development Expense | 1.38M |
| Selling, General and Administrative Expense | 2.28M |
| Operating Income | -724.00K |
| Interest Expense | 873.00K |
| Net Income | -1.63M |
| Net Income Common Stock | -1.63M |
| Net Income Common Stock (USD) | -1.63M |
| Consolidated Income | -1.63M |
| Earnings per Basic Share | -0.17 |
| Earnings per Basic Share (USD) | -0.17 |
| Earnings per Diluted Share | -0.17 |
| Earning Before Interest & Taxes (EBIT) | -756.00K |
| Earning Before Interest & Taxes (USD) | -756.00K |
| Weighted Average Shares | 9.57M |
| Weighted Average Shares Diluted | 9.57M |
| Balance Sheet |
| Cash and Equivalents | 10.84M |
| Cash and Equivalents (USD) | 10.84M |
| Trade and Non-Trade Receivables | 4.30M |
| Current Assets | 22.19M |
| Property, Plant & Equipment Net | 678.00K |
| Total Assets | 24.64M |
| Debt Current | 6.21M |
| Total Debt | 7.26M |
| Current Liabilities | 11.48M |
| Debt Non-Current | 1.06M |
| Total Liabilities | 12.79M |
| Accumulated Retained Earnings (Deficit) | -15.77M |
| Accumulated Other Comprehensive Income | 544.00K |
| Shareholders Equity | 11.85M |
| Shareholders Equity (USD) | 11.85M |
| Assets Non-Current | 2.45M |
| Total Debt (USD) | 7.26M |
| Deferred Revenue | 1.09M |
| Inventory | 6.19M |
| Liabilities Non-Current | 1.31M |
| Trade and Non-Trade Payables | 1.35M |
| Tax Liabilities | 254.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 102.00K |
| Net Cash Flow from Financing | 8.22M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.07M |
| Capital Expenditure | -213.00K |
| Issuance (Purchase) of Equity Shares | 2.12M |
| Issuance (Repayment) of Debt Securities | 6.10M |
| Net Cash Flow from Investing | -213.00K |
| Net Cash Flow from Operations | -2.94M |
| Effect of Exchange Rate Changes on Cash | 64.00K |
| Share Based Compensation | 156.00K |